Journal of Clinical Endocrinology & Metabolism, Vol 60, 891-895, Copyright © 1985 by Endocrine Society

ARTICLES

Morphine inhibits the pituitary-adrenal response to ovine corticotropin- releasing hormone in normal subjects

RS Rittmaster, GB Cutler Jr, DO Sobel, DS Goldstein, MC Koppelman, DL Loriaux and GP Chrousos

To determine the locus of opiate modulation of ACTH secretion, 11 normal subjects were given ovine corticotropin-releasing hormone (CRH) 30 min after receiving either placebo or morphine sulfate. Plasma ACTH, cortisol, arginine vasopressin (AVP), epinephrine, norepinephrine, and CRH were measured 30 min before and up to 150 min after CRH administration. Morphine blunted the ACTH response for the first 60 min and cortisol response for the first 90 min after CRH administration. Morphine did not lower arginine vasopressin or catecholamine levels. To determine whether morphine's effect on ACTH and cortisol was due to a direct action on the corticotroph cell, dispersed rat pituitary cells were perifused with medium containing 1 microgram/ml morphine sulfate or medium alone. Morphine had no effect on the ACTH response of these cells to 10 nM CRH pulses. Similarly, morphine had no effect on ACTH production by dispersed rat pituitary cells in monolayer culture in response to 90- and 180-min incubations with 5 nM CRH. We conclude that morphine blunts the early response of the pituitary gland to CRH in vivo. Based on the lack of a direct effect of morphine on rat pituitary cells in vitro, we postulate that morphine given in vivo may modulate the pituitary ACTH response to CRH through other suprapituitary factors.

This article has been cited by other articles:

				C. Spies, V. Eggers, G. Szabo, A. Lau, V. von Dossow, H. Schoenfeld, H. Althoff, K. Hegenscheid, B. Bohm, T. Schroeder, et al. Intervention at the Level of the Neuroendocrine-Immune Axis and Postoperative Pneumonia Rate in Long-term Alcoholics Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 408 - 414. [Abstract] [Full Text] [PDF]

				M. Vythilingam, G. M. Anderson, M. J. Owens, T. M. Halaszynski, J. D. Bremner, L. L. Carpenter, G. R. Heninger, C. B. Nemeroff, and D. S. Charney Cerebrospinal Fluid Corticotropin-Releasing Hormone in Healthy Humans: Effects of Yohimbine and Naloxone J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4138 - 4145. [Abstract] [Full Text]

				D. Engler, E. Redei, and I. Kola The Corticotropin-Release Inhibitory Factor Hypothesis: A Review of the Evidence for the Existence of Inhibitory as Well as Stimulatory Hypophysiotropic Regulation of Adrenocorticotropin Secretion and Biosynthesis Endocr. Rev., August 1, 1999; 20(4): 460 - 500. [Abstract] [Full Text] [PDF]

				J. A. Yanovski, L. K. Nieman, J. L. Doppman, G. P. Chrousos, R. L. Wilder, P. W. Gold, and K. T. Kalogeras Plasma Levels of Corticotropin-Releasing Hormone in the Inferior Petrosal Sinuses of Healthy Volunteers, Patients with Cushing's Syndrome, and Patients with Pseudo-Cushing States J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1485 - 1488. [Abstract] [Full Text]

				S. Karanth, A. C. E. Linthorst, G. K. Stalla, N. Barden, F. Holsboer, and J. M. H. M. Reul Hypothalamic-Pituitary-Adrenocortical Axis Changes in a Transgenic Mouse with Impaired Glucocorticoid Receptor Function Endocrinology, August 1, 1997; 138(8): 3476 - 3485. [Abstract] [Full Text] [PDF]